Compare Centene Corp (CNC) vs iShares MSCI Indonesia ETF (EIDO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centene Corp vs iShares MSCI Indonesia ETF — how do they compare? Centene Corp trades at $65.77 (market cap $33.93B), while iShares MSCI Indonesia ETF trades at $12. The key difference: Centene Corp is trading nearer its 52-week high, iShares MSCI Indonesia ETF nearer its low. Which is the better fit depends on your goals.
| CNC | EIDO | |
|---|---|---|
Market Cap | $33.93B | — |
Sector | Health | — |
52-Week High | $68.72 | $19.22 |
52-Week Low | $25.21 | $10.80 |
Enterprise Value | $26.56B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Centene Corporation (CNC) trades at $68.29, up 1.4% with strong technical momentum and bullish moving average signals. The stock shows impressive 66% YTD gains, supported by recent contract renewals and margin recovery initiatives. Despite negative 2025 net income of -$6.67B, valuation metrics remain attractive with P/E of 8.06 and P/S of 0.17. Analyst consensus is strongly bullish with 61% buy ratings and $66.07 price target.
Centene presents a compelling value opportunity with low valuation multiples and strong operational cash flow of $5.09B. Key risks include ongoing margin pressure and Medicaid contract dependency. The company's AI-driven cost controls and recent Illinois Medicaid renewal provide catalysts for earnings recovery, though healthcare regulatory changes remain a concern for long-term stability.
EIDO trades at $11.98, up 1.1% today, but technical indicators signal a bearish trend with moving averages and RSI_6 suggesting caution. The ETF's dividend was cut by 27% in 2025, reflecting underlying pressures. Recent news highlights Indonesia's economic initiatives, including AI integration in government programs, which could boost GDP but face currency volatility from Bank Indonesia's rate hikes to defend the rupiah.
Outlook remains mixed: potential growth from Indonesia's economic policies offers opportunity, but risks from currency instability and dividend reductions weigh on investor confidence. The bearish technical setup and lack of recent fundamental data necessitate careful evaluation of emerging market exposure amid global macroeconomic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →About iShares MSCI Indonesia ETF
The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Indonesia. The fund is non-diversified.
Read more on EIDO →
